Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7153047 | 0.79 | AKR1B1 (0.36) | AKR1B1MPI | |
| SCHEMBL18788335 | 0.79 | AKR1B1 (0.36) | AKR1B1MPI | |
| SCHEMBL2323870 | 0.79 | AKR1B1 (0.36) | AKR1B1MPI | |
| SCHEMBL2319489 | 0.79 | AKR1B1 (0.36) | AKR1B1MPI | |
| SCHEMBL3357554 | 0.79 | AKR1B1 (0.36) | AKR1B1MPI | |
| SCHEMBL2319597 | 0.79 | AKR1B1 (0.36) | AKR1B1MPI | |
| SCHEMBL18018688 | 0.78 | AKR1B1 (0.34) | AKR1B1 | |
| SCHEMBL3341668 | 0.75 | MPI (0.43) | AKR1B1MPI | |
| SCHEMBL1672719 | 0.75 | MPI (0.43) | AKR1B1MPI | |
| SCHEMBL14060173 | 0.75 | AKR1B1 (0.32) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391719-B2 | Methods for producing stereoisomerically enriched carbohydrate-based surfactants | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250243232-A1 | GLYONIC LIQUIDS AND USES THEREOF | Arizona Board of Regents on the behalf of the University of Arizona (US) | 2025-07-31 | — | — | US | disclosed |
| US-12226488-B2 | Nitroreductase-releasable pro-drugs and methods for using the same | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-02-18 | — | — | US | disclosed |
| US-20250051624-A1 | DUST SUPPRESSANT COMPOSITION COMPRISING GLYCOLIPID | NATIONAL INSTITUTES OF HEALTH | 2025-02-13 | — | — | US | disclosed |
| US-20250051526-A1 | POLYMERS COMPRISING GLYCOLIPIDS AND METHODS FOR PRODUCING AND USING THE SAME | NATIONAL INSTITUTES OF HEALTH | 2025-02-13 | — | — | US | disclosed |
| US-20240352075-A1 | PACAP1-23 ANALOG GLYCOPEPTIDES AND METHODS FOR PRODUCING AND USING THE SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-10-24 | — | — | US | disclosed |
| US-20240294595-A1 | GLYCOPEPTIDES AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2024-09-05 | — | — | US | disclosed |
| US-20240182513-A1 | SEPARATION OF METAL IONS FROM A SAMPLE USING GLYCOLIPIDS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2024-06-06 | — | — | US | disclosed |
| US-20230265124-A1 | OXYTOCIN ANALOGUES AND METHODS FOR USING THE SAME | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2023-08-24 | — | — | US | disclosed |
| WO-2023114778-A1 | POLYMERS COMPRISING GLYCOLIPIDS AND METHODS FOR PRODUCING AND USING THE SAME | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2022026463-A1 | OXYTOCIN ANALOGUES AND METHODS FOR USING THE SAME | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-02-03 | — | — | WO | disclosed |
| US-20220017556-A1 | METHODS FOR PRODUCING STEREOISOMERICALLY ENRICHED CARBOHYDRATE-BASED SURFACTANTS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-01-20 | — | — | US | disclosed |
| US-20210403499-A1 | CARBOHYDRATE-BASED SURFACTANTS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-12-30 | — | — | US | disclosed |
| US-11117914-B2 | Carbohydrate-based surfactants | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-09-14 | — | — | US | disclosed |
| WO-2020210175-A1 | NITROREDUCTASE-RELEASABLE PRO-DRUGS AND METHODS FOR USING THE SAME | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2020-10-15 | — | — | WO | disclosed |
| WO-2020163839-A1 | GLYONIC LIQUIDS AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2020-08-13 | — | — | WO | disclosed |
| US-20170121362-A1 | CARBOHYDRATE-BASED SURFACTANTS | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2017-05-04 | — | — | US | disclosed |
| US-20160346399-A1 | DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2016-12-01 | — | — | US | disclosed |
| US-6380168-B1 | ADMINISTERING 3-O-.BETA.-GLUCOPYRANOSYL(1-6)-.BETA.-D-GLUCOPYRANOSYL INDOLE, 2-S-.BETA.-D-GLUCOPYRANOSYL-3-O-.BETA.-D-GLUCOPYRANOSYL-2-MERC APTOINDOLE FOR INCREASING BLOOD FLOW TO SKIN | NOMURA CO., LTD. (JP) | 2002-04-30 | — | — | US | disclosed |
| US-6297363-B1 | 3-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL INDOLE; ISOLATED FROM CALANTHE DISCOLOR LINDL; FOR PROMOTION OF HAIR GROWTH AND RESTORATION | NOMURA CO., LTD. (JP) | 2001-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12226488-B2 | Nitroreductase-releasable pro-drugs and methods for using the same | AKR1B1, AKR1A1, POR | AKR1B1 1/4885MPI 3165/4885 |
| US-20250051526-A1 | POLYMERS COMPRISING GLYCOLIPIDS AND METHODS FOR PRODUCING AND USING THE SAME | ALG1, SGMS2, SGMS1 | AKR1B1 1605/4885MPI 33/4885 |
| US-20250243232-A1 | GLYONIC LIQUIDS AND USES THEREOF | GCG, B3GAT3, CA6 | AKR1B1 1394/4885MPI 337/4885 |
| US-12391719-B2 | Methods for producing stereoisomerically enriched carbohydrate-based surfactants | DDOST, CEL, SI | AKR1B1 532/4885MPI 43/4885 |
| US-20230265124-A1 | OXYTOCIN ANALOGUES AND METHODS FOR USING THE SAME | OXTR, AVPR2, ADM2 | AKR1B1 475/4885MPI 1215/4885 |
| US-20170121362-A1 | CARBOHYDRATE-BASED SURFACTANTS | DDOST, CSGALNACT1, MUC1 | AKR1B1 1769/4885MPI 58/4885 |
| US-11117914-B2 | Carbohydrate-based surfactants | DDOST, CSGALNACT1, MUC1 | AKR1B1 1769/4885MPI 58/4885 |
| US-20240182513-A1 | SEPARATION OF METAL IONS FROM A SAMPLE USING GLYCOLIPIDS | SGMS2, SGMS1, UGCG | AKR1B1 3774/4885MPI 204/4885 |
| US-20160346399-A1 | DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | SI, EPX, CD44 | AKR1B1 667/4885MPI 786/4885 |
| US-20210403499-A1 | CARBOHYDRATE-BASED SURFACTANTS | DDOST, CSGALNACT1, MUC1 | AKR1B1 1769/4885MPI 58/4885 |
| US-20220017556-A1 | METHODS FOR PRODUCING STEREOISOMERICALLY ENRICHED CARBOHYDRATE-BASED SURFACTANTS | DDOST, CEL, SI | AKR1B1 532/4885MPI 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.